300 related articles for article (PubMed ID: 33250706)
1. Comparison of Common and Disease-Specific Post-translational Modifications of Pathological Tau Associated With a Wide Range of Tauopathies.
Kametani F; Yoshida M; Matsubara T; Murayama S; Saito Y; Kawakami I; Onaya M; Tanaka H; Kakita A; Robinson AC; Mann DMA; Hasegawa M
Front Neurosci; 2020; 14():581936. PubMed ID: 33250706
[TBL] [Abstract][Full Text] [Related]
2. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
3. Distinct tau folds initiate templated seeding and alter the post-translational modification profile.
Tarutani A; Kametani F; Tahira M; Saito Y; Yoshida M; Robinson AC; Mann DMA; Murayama S; Tomita T; Hasegawa M
Brain; 2023 Dec; 146(12):4988-4999. PubMed ID: 37904205
[TBL] [Abstract][Full Text] [Related]
4. Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains.
Arakhamia T; Lee CE; Carlomagno Y; Duong DM; Kundinger SR; Wang K; Williams D; DeTure M; Dickson DW; Cook CN; Seyfried NT; Petrucelli L; Fitzpatrick AWP
Cell; 2020 Feb; 180(4):633-644.e12. PubMed ID: 32032505
[TBL] [Abstract][Full Text] [Related]
5. The Role of Tau Proteoforms in Health and Disease.
Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
[TBL] [Abstract][Full Text] [Related]
6. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
[TBL] [Abstract][Full Text] [Related]
7. Novel tau filament fold in corticobasal degeneration.
Zhang W; Tarutani A; Newell KL; Murzin AG; Matsubara T; Falcon B; Vidal R; Garringer HJ; Shi Y; Ikeuchi T; Murayama S; Ghetti B; Hasegawa M; Goedert M; Scheres SHW
Nature; 2020 Apr; 580(7802):283-287. PubMed ID: 32050258
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies.
Rawat P; Sehar U; Bisht J; Selman A; Culberson J; Reddy PH
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361631
[TBL] [Abstract][Full Text] [Related]
9. Specific post-translational modifications of soluble tau protein distinguishes Alzheimer's disease and primary tauopathies.
Kyalu Ngoie Zola N; Balty C; Pyr Dit Ruys S; Vanparys AAT; Huyghe NDG; Herinckx G; Johanns M; Boyer E; Kienlen-Campard P; Rider MH; Vertommen D; Hanseeuw BJ
Nat Commun; 2023 Jun; 14(1):3706. PubMed ID: 37349319
[TBL] [Abstract][Full Text] [Related]
10. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
11. Invited review: Neuropathology of tauopathies: principles and practice.
Kovacs GG
Neuropathol Appl Neurobiol; 2015 Feb; 41(1):3-23. PubMed ID: 25495175
[TBL] [Abstract][Full Text] [Related]
12. Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
Hosokawa M; Masuda-Suzukake M; Shitara H; Shimozawa A; Suzuki G; Kondo H; Nonaka T; Campbell W; Arai T; Hasegawa M
Brain; 2022 Mar; 145(1):349-361. PubMed ID: 34515757
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.
Mukherjee S; Dubois C; Perez K; Varghese S; Birchall IE; Leckey M; Davydova N; McLean C; Nisbet RM; Roberts BR; Li QX; Masters CL; Streltsov VA
J Neurochem; 2023 Feb; 164(4):529-552. PubMed ID: 36271678
[TBL] [Abstract][Full Text] [Related]
14. Tau exhibits unique seeding properties in globular glial tauopathy.
Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
[TBL] [Abstract][Full Text] [Related]
15. Function and regulation of cis P-tau in the pathogenesis and treatment of conventional and nonconventional tauopathies.
Wang R; Lu KP; Zhou XZ
J Neurochem; 2023 Sep; 166(6):904-914. PubMed ID: 37638382
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.
Khanna MR; Kovalevich J; Lee VM; Trojanowski JQ; Brunden KR
Alzheimers Dement; 2016 Oct; 12(10):1051-1065. PubMed ID: 27751442
[TBL] [Abstract][Full Text] [Related]
17. Distinct phosphorylation profiles of tau in brains of patients with different tauopathies.
Samimi N; Sharma G; Kimura T; Matsubara T; Huo A; Chiba K; Saito Y; Murayama S; Akatsu H; Hashizume Y; Hasegawa M; Farjam M; Shahpasand K; Ando K; Hisanaga SI
Neurobiol Aging; 2021 Dec; 108():72-79. PubMed ID: 34536819
[TBL] [Abstract][Full Text] [Related]
18. Biochemistry and molecular biology of tauopathies.
Hasegawa M
Neuropathology; 2006 Oct; 26(5):484-90. PubMed ID: 17080729
[TBL] [Abstract][Full Text] [Related]
19. The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M; Probst A
IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
[TBL] [Abstract][Full Text] [Related]
20. Structure-based classification of tauopathies.
Shi Y; Zhang W; Yang Y; Murzin AG; Falcon B; Kotecha A; van Beers M; Tarutani A; Kametani F; Garringer HJ; Vidal R; Hallinan GI; Lashley T; Saito Y; Murayama S; Yoshida M; Tanaka H; Kakita A; Ikeuchi T; Robinson AC; Mann DMA; Kovacs GG; Revesz T; Ghetti B; Hasegawa M; Goedert M; Scheres SHW
Nature; 2021 Oct; 598(7880):359-363. PubMed ID: 34588692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
